10 Questions β’ Answer all questions and submit to see your results
Select one answer for each question
Quiz Complete! π
Answer Review
Review all questions with correct answers and explanations
π Revision Notes
Key takeaways from today’s quiz to strengthen your preparation
π΄ Revision Flashcards
Click each card to flip and test your recall
Should pharmaceutical research and global health funding prioritize diseases based on their human impact (death, disability, suffering) or is it acceptable that market forcesβwhich favor profitable diseases over impactful onesβdrive medical priorities?
- Would mandatory licensing (allowing generic production) of NTD treatments in affected countries be justified, even if it reduces pharmaceutical profits and innovation incentives?
- Do wealthy nations have a moral obligation to fund NTD research and treatment, or is global health aid a voluntary charity rather than an obligation? Where does responsibility for global health inequity lie?
- Can market-based solutions (advance purchase commitments, patent prizes) adequately address NTDs, or do some health challenges require non-market interventions regardless of economic efficiency?
We’d love to hear your thoughts! Share your perspective in the comments.
π€ Found this useful? Help your friends stay updated too!